The molecular classification system is useful for determining the likelihood of complete pathologic response to neoadjuvant chemotherapy in locally advance breast cancer

被引：0
|
作者：
Young, M. [1 ]
Goldstein, N. S. [1 ]
机构：
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
232
引用
收藏
页码：55A / 55A
页数：1
相关论文
共 50 条
  • [1] The molecular classification system is useful for determining the likelihood of complete pathologic response to neoadjuvant chemotherapy in locally advance breast cancer
    Young, M.
    Goldstein, N. S.
    LABORATORY INVESTIGATION, 2007, 87 : 55A - 55A
  • [2] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [3] Pathologic complete response rates following neoadjuvant chemotherapy in the treatment of locally advanced breast cancer
    Prabhudesai, S. R.
    Malini, A. V.
    Raghavendra, R. M.
    Ashwini, N. R.
    Geetha, V. P.
    Patil, S.
    Diwakar, R. B.
    Gopinath, K. S.
    Srinath, B. S.
    Raizada, N.
    Somorat, B.
    Naik, R.
    Giri, S. P.
    Ajaikumar, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer
    Al-Tweigeri, Taher
    Elshenawy, Mahmoud
    Badran, Ahmed
    Omar, Ayman
    Suleman, Kausar
    Al Malik, Osama
    Anwar, Ihab
    Jastaniya, Noha
    Tulbah, Asma
    Al Shabanah, Mohammad
    Ajarim, Dahish
    Al Sayed, Adher
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [5] Molecular analysis in breast cancer: correlation with immunohistochemical classification and pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)
    Baulies, S.
    Gonzalez-Cao, M.
    Karachaliou, N.
    Rodriguez Capitan, A.
    Molina-Vila, M. A.
    Cusido, M. T.
    Teixido, C.
    Viteri, S.
    Fabregas, R.
    Gonzalez, X.
    Rosell, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 85 - 85
  • [6] Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
    Waqar Haque
    Vivek Verma
    Sandra Hatch
    V. Suzanne Klimberg
    E. Brian Butler
    Bin S. Teh
    Breast Cancer Research and Treatment, 2018, 170 : 559 - 567
  • [7] Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
    Haque, Waqar
    Verma, Vivek
    Hatch, Sandra
    Klimberg, V. Suzanne
    Butler, E. Brian
    Teh, Bin S.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (03) : 559 - 567
  • [8] Can MRI Predict Pathologic Complete Response After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer?
    Lee, C.
    Le-Tran, V.
    Olimpiadi, Y.
    Zaremba, N.
    Nelson, M.
    Lang, J. E.
    Sener, S. F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S90 - S90
  • [9] Complete pathologic response after neoadjuvant chemotherapy in locally advanced colon cancer
    Arredondo, Jorge
    Simo, Vicente
    Castanon, Carmen
    Jose Suarez, Maria
    Concepcion Alvarez, Maria
    CIRUGIA ESPANOLA, 2020, 98 (03): : 168 - 170
  • [10] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    CANCER RESEARCH, 2010, 70
12345